KRYSTAL BIOTECH INC's ticker is KRYS and the CUSIP is 501147102. A total of 113 filers reported holding KRYSTAL BIOTECH INC in Q2 2020. The put-call ratio across all filers is 1.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $103,000 | -61.6% | 1,975 | -50.0% | 0.00% | – |
| Q2 2021 | $268,000 | -11.8% | 3,950 | 0.0% | 0.00% | -100.0% |
| Q1 2021 | $304,000 | -76.7% | 3,950 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $1,304,000 | +667.1% | 3,950 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $170,000 | +3.7% | 3,950 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $164,000 | +925.0% | 3,950 | +953.3% | 0.00% | – |
| Q1 2020 | $16,000 | -23.8% | 375 | 0.0% | 0.00% | – |
| Q4 2019 | $21,000 | -89.5% | 375 | -93.5% | 0.00% | -100.0% |
| Q3 2019 | $200,000 | +51.5% | 5,765 | +76.0% | 0.00% | 0.0% |
| Q2 2019 | $132,000 | +22.2% | 3,275 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $108,000 | +77.0% | 3,275 | +12.0% | 0.00% | 0.0% |
| Q4 2018 | $61,000 | +56.4% | 2,925 | +31.5% | 0.00% | – |
| Q3 2018 | $39,000 | +18.2% | 2,225 | 0.0% | 0.00% | – |
| Q2 2018 | $33,000 | +50.0% | 2,225 | 0.0% | 0.00% | – |
| Q1 2018 | $22,000 | +100.0% | 2,225 | +122.5% | 0.00% | – |
| Q4 2017 | $11,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 1,913,280 | $153,177,197 | 6.65% |
| Frazier Life Sciences Management, L.P. | 945,407 | $75,689,284 | 5.48% |
| S Squared Technology, LLC | 108,215 | $8,663,693 | 5.14% |
| Nicholas Investment Partners, LP | 374,718 | $29,999,923 | 2.28% |
| Avoro Capital Advisors LLC | 1,750,000 | $140,105,000 | 2.08% |
| Artal Group S.A. | 412,082 | $32,991 | 1.96% |
| First Light Asset Management, LLC | 195,980 | $15,690,159 | 1.41% |
| Integral Health Asset Management, LLC | 85,000 | $6,805,100 | 1.37% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 61,000 | $4,883,660 | 1.36% |
| Hood River Capital Management LLC | 447,393 | $35,818,000 | 1.16% |